tiprankstipranks
Trending News
More News >
4D Molecular Therapeutics, Inc. (FDMT)
:FDMT
US Market

4D Molecular Therapeutics (FDMT) Cash flow

Compare
486 Followers

4D Molecular Therapeutics Cash Flow

FDMT's free cash flow for Q3 2025 was $-46.41M. For the 2025 fiscal year, FDMT's free cash flow was decreased by $-59.81M and operating cash flow was $-46.50M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -134.59M$ -75.79M$ -86.69M$ -69.13M$ -50.91M
Investing Cash Flow
$ -302.44M$ 115.72M$ -17.05M$ -172.68M$ -1.00M
Financing Cash Flow
$ 337.25M$ 156.83M$ 3.08M$ 118.09M$ 278.98M
End Cash Position
$ 149.34M$ 249.11M$ 52.35M$ 153.00M$ 276.73M
Free Cash Flow
$ -138.37M$ -78.56M$ -98.22M$ -78.24M$ -51.91M
Currency in USD

4D Molecular Therapeutics Cash Flow